Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.37 |
| ▸ | CHRNA10 | Q9GZZ6 | 3/20 | 0.37 |
| ▸ | CHRNA9 | Q9UGM1 | 3/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20923487 | 0.98 | SIGMAR1 (0.38) | SIGMAR1MAOAACHECHRNA7CHRNA10 | |
| Hydrochloric Acid SCHEMBL21051230 | 0.92 | CHRNA7 (0.44) | SIGMAR1MAOACHRNA7CHRNA10CHRNA9 | |
| SCHEMBL28185788 | 0.91 | SIGMAR1 (0.38) | SIGMAR1 | |
| SCHEMBL8369382 | 0.89 | CYP2D6 (0.40) | MAOAMAOBHTR2A | |
| Hydrochloric Acid SCHEMBL21082787 | 0.87 | CYP2D6 (0.39) | MAOAMAOBHTR2A | |
| Bromide SCHEMBL1885288 | 0.81 | CHRNA7 (0.40) | SIGMAR1CHRNA7CHRNA10CHRNA9MAOB | |
| Bromide SCHEMBL1883010 | 0.81 | CHRNA7 (0.46) | CHRNA7CHRNA10CHRNA9 | |
| Bromide SCHEMBL1889476 | 0.81 | CHRNA7 (0.40) | CHRNA7CHRNA10CHRNA9HTR2A | |
| Bromide SCHEMBL1887326 | 0.81 | CHRNA7 (0.40) | MAOACHRNA7CHRNA10CHRNA9MAOB | |
| Benzylimidazole SCHEMBL339106 | 0.81 | ALDH1A1 (0.46) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020152206-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2020-07-30 | — | — | WO | disclosed |
| EP-2474527-B1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEM IND LTD (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | SIGMAR1 413/4885MAOA 4875/4885ACHE 4640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.